322 related articles for article (PubMed ID: 17557337)
21. Pathogenic mechanisms in Huntington's disease.
Jones L; Hughes A
Int Rev Neurobiol; 2011; 98():373-418. PubMed ID: 21907095
[TBL] [Abstract][Full Text] [Related]
22. [Study of the association of genotype and phenotype features of the pathogenesis of Huntington's chorea].
Hryshchenko NV; Kucherenko AM; Patskun EI; Livshyts' LA
Tsitol Genet; 2009; 43(3):42-7. PubMed ID: 19938636
[TBL] [Abstract][Full Text] [Related]
23. Huntington's disease: the current state of research with peripheral tissues.
Sassone J; Colciago C; Cislaghi G; Silani V; Ciammola A
Exp Neurol; 2009 Oct; 219(2):385-97. PubMed ID: 19460373
[TBL] [Abstract][Full Text] [Related]
24. The use of transgenic and knock-in mice to study Huntington's disease.
Hickey MA; Chesselet MF
Cytogenet Genome Res; 2003; 100(1-4):276-86. PubMed ID: 14526189
[TBL] [Abstract][Full Text] [Related]
25. Dysfunctional Dopaminergic Neurones in Mouse Models of Huntington's Disease: A Role for SK3 Channels.
Dallérac GM; Levasseur G; Vatsavayai SC; Milnerwood AJ; Cummings DM; Kraev I; Huetz C; Evans KA; Walters SW; Rezaie P; Cho Y; Hirst MC; Murphy KP
Neurodegener Dis; 2015; 15(2):93-108. PubMed ID: 25871323
[TBL] [Abstract][Full Text] [Related]
26. Magnetization transfer imaging in 'premanifest' Huntington's disease.
Jurgens CK; Bos R; Luyendijk J; Witjes-Ané MN; van der Grond J; Middelkoop HA; Roos RA
J Neurol; 2010 Mar; 257(3):426-32. PubMed ID: 19823894
[TBL] [Abstract][Full Text] [Related]
27. Huntingtin protein colocalizes with lesions of neurodegenerative diseases: An investigation in Huntington's, Alzheimer's, and Pick's diseases.
Singhrao SK; Thomas P; Wood JD; MacMillan JC; Neal JW; Harper PS; Jones AL
Exp Neurol; 1998 Apr; 150(2):213-22. PubMed ID: 9527890
[TBL] [Abstract][Full Text] [Related]
28. Gene expression profile in fibroblasts of Huntington's disease patients and controls.
Marchina E; Misasi S; Bozzato A; Ferraboli S; Agosti C; Rozzini L; Borsani G; Barlati S; Padovani A
J Neurol Sci; 2014 Feb; 337(1-2):42-6. PubMed ID: 24296361
[TBL] [Abstract][Full Text] [Related]
29. Early mitochondrial calcium defects in Huntington's disease are a direct effect of polyglutamines.
Panov AV; Gutekunst CA; Leavitt BR; Hayden MR; Burke JR; Strittmatter WJ; Greenamyre JT
Nat Neurosci; 2002 Aug; 5(8):731-6. PubMed ID: 12089530
[TBL] [Abstract][Full Text] [Related]
30. Mitochondrial structural and functional dynamics in Huntington's disease.
Reddy PH; Mao P; Manczak M
Brain Res Rev; 2009 Jun; 61(1):33-48. PubMed ID: 19394359
[TBL] [Abstract][Full Text] [Related]
31. Extended polyglutamine repeats trigger a feedback loop involving the mitochondrial complex III, the proteasome and huntingtin aggregates.
Fukui H; Moraes CT
Hum Mol Genet; 2007 Apr; 16(7):783-97. PubMed ID: 17356014
[TBL] [Abstract][Full Text] [Related]
32. Increased apoptosis, Huntingtin inclusions and altered differentiation in muscle cell cultures from Huntington's disease subjects.
Ciammola A; Sassone J; Alberti L; Meola G; Mancinelli E; Russo MA; Squitieri F; Silani V
Cell Death Differ; 2006 Dec; 13(12):2068-78. PubMed ID: 16729030
[TBL] [Abstract][Full Text] [Related]
33. Counting CAG repeats in the Huntington's disease gene by restriction endonuclease EcoP15I cleavage.
Möncke-Buchner E; Reich S; Mücke M; Reuter M; Messer W; Wanker EE; Krüger DH
Nucleic Acids Res; 2002 Aug; 30(16):e83. PubMed ID: 12177311
[TBL] [Abstract][Full Text] [Related]
34. Is There Convincing Evidence that Intermediate Repeats in the HTT Gene Cause Huntington's Disease?
Oosterloo M; Van Belzen MJ; Bijlsma EK; Roos RA
J Huntingtons Dis; 2015; 4(2):141-8. PubMed ID: 26397895
[TBL] [Abstract][Full Text] [Related]
35. Bioenergetics in Huntington's disease.
Grünewald T; Beal MF
Ann N Y Acad Sci; 1999; 893():203-13. PubMed ID: 10672239
[TBL] [Abstract][Full Text] [Related]
36. Identification and characterization of the miniature pig Huntington's disease gene homolog: evidence for conservation and polymorphism in the CAG triplet repeat.
Matsuyama N; Hadano S; Onoe K; Osuga H; Showguchi-Miyata J; Gondo Y; Ikeda JE
Genomics; 2000 Oct; 69(1):72-85. PubMed ID: 11013077
[TBL] [Abstract][Full Text] [Related]
37. Huntington's disease: clinical presentation and treatment.
Novak MJ; Tabrizi SJ
Int Rev Neurobiol; 2011; 98():297-323. PubMed ID: 21907093
[TBL] [Abstract][Full Text] [Related]
38. Age-dependent and tissue-specific CAG repeat instability occurs in mouse knock-in for a mutant Huntington's disease gene.
Ishiguro H; Yamada K; Sawada H; Nishii K; Ichino N; Sawada M; Kurosawa Y; Matsushita N; Kobayashi K; Goto J; Hashida H; Masuda N; Kanazawa I; Nagatsu T
J Neurosci Res; 2001 Aug; 65(4):289-97. PubMed ID: 11494364
[TBL] [Abstract][Full Text] [Related]
39. [From gene to disease; HD gene and Huntington disease].
Maat-Kievit JA; Losekoot M; Roos RA
Ned Tijdschr Geneeskd; 2001 Nov; 145(44):2120-3. PubMed ID: 11723754
[TBL] [Abstract][Full Text] [Related]
40. Glutathione S-Transferase Omega 1 variation does not influence age at onset of Huntington's disease.
Arning L; Jagiello P; Wieczorek S; Saft C; Andrich J; Epplen JT
BMC Med Genet; 2004 Mar; 5():7. PubMed ID: 15040808
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
